Welcome to our dedicated page for Cra Intl news (Ticker: CRAI), a resource for investors and traders seeking the latest updates and insights on Cra Intl stock.
Charles River Associates, the registered trade name of CRA International, Inc. (NASDAQ: CRAI), regularly issues news and updates that reflect its role as a global consulting firm specializing in economic, financial, and management consulting services. This news page aggregates announcements that describe how CRA advises on economic and financial matters in litigation and regulatory proceedings and supports corporations with business strategy and performance-related issues.
Investors and observers can use this feed to follow earnings announcements, dividend declarations, and conference participation. Recent press releases have covered quarterly financial results, changes to the company’s quarterly cash dividend, and details of webcasts and conference calls hosted by CRA’s leadership team. The company also reports on its participation in investor conferences such as events organized by UBS, Noble Capital Markets, and Sidoti.
CRA’s news flow also highlights developments in its specialized practices. Announcements have described the strengthening of the Forensic Services Practice, which focuses on cybercrime, digital forensics, forensic accounting, and eDiscovery matters, and the Antitrust & Competition Economics Practice, whose economists provide economic analysis and testimony in competition matters around the world. Additional releases discuss the expansion of the Risk, Investigations & Analytics Practice and the activities of the Energy Practice, including serving as RFP Manager for a Renewable Energy Credits Request for Proposal for FirstEnergy’s Ohio utilities.
By reviewing the CRAI news page on Stock Titan, readers can track how CRA International, Inc. communicates about its financial performance, practice-area growth, risk and investigations work, antitrust and competition economics expertise, and energy-sector engagements. This context can help users understand the types of matters the firm handles and how its consulting capabilities evolve over time.
Charles River Associates (NASDAQ: CRAI) announced that Nate Goldstein has joined as a Vice President in its Antitrust & Competition Economics Practice on November 4, 2025.
Goldstein brings a 23-year career at the Antitrust Division of the U.S. Department of Justice, including service as Chief of the Division’s Economic Litigation Section, and has led more than 150 federal investigations into mergers, monopolization, contractual restraints, and criminal conspiracy. CRA highlighted his experience supervising economists, data scientists, financial analysts, and visiting academics. Goldstein holds an AB in Economics from Duke and an MA and PhD in Economics from Stanford.
Charles River Associates (NASDAQ: CRAI) reported third-quarter fiscal 2025 results with revenue of $185.9 million, up 10.8% YoY. GAAP net income was $11.5 million (6.2% margin) and non‑GAAP net income was $13.7 million (7.3% of revenue), up 12.7% YoY. Non‑GAAP EPS rose 16.4% YoY to $2.06; GAAP diluted EPS was $1.73. Non‑GAAP EBITDA was $24.4 million, up 14.6% YoY. Year‑to‑date revenue on a constant currency basis is $552.1 million. Management raised full‑year fiscal 2025 revenue guidance to $740.0M–$748.0M and increased the lower end of non‑GAAP EBITDA margin guidance to 12.6%–13.0%. CRA returned $7.2M to shareholders and raised the quarterly dividend 16% to $0.57 per share (payable Dec 12, 2025; record Nov 25, 2025).
Charles River Associates (NASDAQ: CRAI) announced a 16% increase in its quarterly cash dividend from $0.49 to $0.57 per common share.
The dividend is payable on December 12, 2025 to shareholders of record as of the close of business on November 25, 2025. The company said it expects to continue paying quarterly dividends, but declarations, timing and amounts remain at the discretion of CRA’s Board of Directors.
Charles River Associates (NASDAQ: CRAI) announced on October 28, 2025 that Dr. Keler Marku has joined as a Vice President in the Antitrust & Competition Economics Practice. The company highlighted Dr. Marku's expertise in industrial organization, microeconomic theory, data science, and work on generative AI competition and IP matters.
Charles River Associates noted Dr. Marku's prior role as a Senior Principal at an economic, technology, and strategic advisory firm where he supported testifying experts and advised on regulatory investigations across multiple industries. Dr. Marku holds a BS in Mathematics and Economics, an MA in Economics from the University of Nebraska–Lincoln, and a PhD in Economics from the University of Minnesota.
Charles River Associates (NASDAQ: CRAI) announced that Andrew Rosini joined its Risk, Investigations & Analytics Practice as a Vice President on October 21, 2025. He brings 20+ years advising on domestic and international investigations with a focus on financial crimes, compliance across financial products, and both traditional and decentralized finance.
Rosini previously led professional services at a boutique investigations and digital forensics firm and spent 14 years at a business advisory firm, including six years as managing director of global risk and investigations overseeing 200+ professionals. He has directed crypto asset recovery, transaction monitoring, governance and KYC remediation work, served in regulator and court oversight roles, and provided expert testimony in securities fraud matters. Rosini holds an MBA in Accounting and Finance and a BA in History from Fordham University.
Charles River Associates (NASDAQ: CRAI) will webcast its third-quarter 2025 financial results conference call on Thursday, October 30, 2025 at 10:00 a.m. ET. The call will be hosted by President & CEO Paul Maleh, CFO Eric Nierenberg, and Chief Corporate Development Officer Chad Holmes.
Investors can listen via the live webcast in the Investor Relations section at http://www.crai.com or by telephone at (877) 709-8155 or (201) 689-8881. The company will post the press release, supplemental financial information, and prepared CFO remarks before the call. An archived webcast, press release, and financial materials will be available on the website for one year.
CRA International (NASDAQ: CRAI) announced it will manage a Request for Proposal (RFP) process for FirstEnergy Corp.'s Ohio subsidiaries to procure Renewable Energy Credits (RECs). The RFP seeks both solar and non-solar RECs that must be eligible for the Companies' 2025 renewable energy obligations.
The RECs must be sourced from PUCO-certified facilities, deliverable through PJM Environmental Information System, and generated between January 1, 2023, and December 31, 2025. An RFP Overview Webinar for prospective bidders is scheduled for October 2, 2025, with final submissions due by November 4, 2025.
CRA International (NASDAQ: CRAI) has announced the opening of applications for FirstEnergy Pennsylvania Electric Company's Default Service Program DSP-VI auction. The auction, scheduled for November 12, 2025, will use a descending-price clock format to procure full requirements Default Supply generation service.
The process includes two application phases: Part 1 Applications due by October 9, and Part 2 Applications from October 16 to October 30. The auction will offer both 12-month and 24-month products for residential and commercial classes, with delivery periods extending from June 2026 through May 2028.
Charles River Associates (NASDAQ: CRAI), a leading economic and management consulting firm, announced its participation in the Noble Capital Markets Emerging Growth Virtual Investor Conference. CEO Paul Maleh will present on October 8, 2025, at 9:00 a.m. ET.
The company's leadership team, including CFO Eric Nierenberg and Chief Corporate Development Officer Chad Holmes, will be available for investor meetings. An archived webcast of the presentation will be accessible through CRA's investor relations website.
Charles River Associates (NASDAQ: CRAI) has announced the appointment of Frances Hendry as Vice President in its Life Sciences Practice. Hendry brings significant experience in pharmaceutical consulting, specializing in product launches and portfolio optimization. Prior to joining CRA, she served as Vice President at a healthcare consulting firm and held senior roles at a U.K. marketing consultancy.
Hendry holds an MA in Business Management from Glasgow University, an MSC in Marketing from Edinburgh Napier University, and a CIM Postgraduate Diploma from Cambridge Marketing College. The appointment aligns with CRA's focus on strengthening client relationships and expanding its life sciences consulting capabilities.